Oncimmune raises €2.6M Post IPO round
30 November 2024· Leeds, United Kingdom· health, biotechnology, diagnostics, ai, b2b, software_hardware
to support the Group with near term working capital and future growth
Investors
LeadIPF Partners
About Oncimmune
Stage
Post IPO
Headquarters
Leeds, United Kingdom
Founded
2002
Team Size
21–50
Sectors
healthbiotechnologydiagnosticsaib2bsoftware_hardware